Singapore Clinical Trial: An Open-Label, Rollover Study for Participants with Thyroid Eye Disease Previously Enrolled in Amgen-Sponsored AMG 732 Studies and are Primary Proptosis Non-Responders or Who Relapsed During the Safety Follow-Up

Singapore, Aug. 15 -- The Health Sciences Authority received information related to the study titled 'An Open-Label, Rollover Study for Participants with Thyroid Eye Disease Previously Enrolled in Amgen-Sponsored AMG 732 Studies and are Primary Proptosis Non-Responders or Who Relapsed During the Safety Follow-Up'. The following are the other relevant details related to the trial:

Therapeutic Area: Ophthalmology

Trial Centre(s): National University Hospital Singapore National Eye Centre

Trial Status: NA

Principal Investigator(s): Dr Blanche Lim Dr Stephen Ng

Published by HT Digital Content Services with permission from Health Daily Digest....